Vahid Vahedi - Aug 1, 2023 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Signature
Marta Woods by Power of Attorney
Stock symbol
LRCX
Transactions as of
Aug 1, 2023
Transactions value $
-$7,050,834
Form type
4
Date filed
8/2/2023, 04:45 PM
Previous filing
Mar 3, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $680K +3.58K +13.5% $190.07 30.1K Aug 1, 2023 Direct F1
transaction LRCX Common Stock Sale -$2.57M -3.58K -11.9% $717.53 26.5K Aug 1, 2023 Direct F1
transaction LRCX Common Stock Options Exercise $1.31M +7.43K +28.06% $176.75 33.9K Aug 1, 2023 Direct F1
transaction LRCX Common Stock Sale -$5.33M -7.43K -21.91% $717.52 26.5K Aug 1, 2023 Direct F1, F2
transaction LRCX Common Stock Options Exercise $825K +2.75K +10.38% $300.33 29.2K Aug 1, 2023 Direct F1
transaction LRCX Common Stock Sale -$1.97M -2.75K -9.4% $717.23 26.5K Aug 1, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -3.58K -100% $0.00* 0 Aug 1, 2023 Common Stock 3.58K $190.07 Direct F4
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -7.43K -100% $0.00* 0 Aug 1, 2023 Common Stock 7.43K $176.75 Direct F5
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -2.75K -100% $0.00* 0 Aug 1, 2023 Common Stock 2.75K $300.33 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount reported includes shares subject to unvested restricted stock units.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $717.26 to $718.10, inclusive.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $716.91 to $717.32, inclusive.
F4 The stock option becomes exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021.
F5 The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022.
F6 The stock option becomes exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.